Is the Measles, Mumps, and Rubella (MMR) vaccine given in two doses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MMR Vaccine Two-Dose Schedule

Yes, the MMR vaccine is routinely given as a two-dose series, with the first dose administered at 12-15 months of age and the second dose at 4-6 years of age. 1, 2

Standard Vaccination Schedule

Children

  • First dose: Administer at age 12-15 months 3, 2
  • Second dose: Administer at age 4-6 years (before kindergarten or first grade entry) 3, 2
  • Minimum interval between doses: 28 days (4 weeks) 1, 2

This two-dose schedule has been jointly adopted by the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). 3

Adults

  • Persons born in 1957 or later: At least one dose of MMR vaccine is required unless they have documentation of vaccination or other acceptable evidence of immunity 3
  • High-risk adults: Two doses are recommended for students in postsecondary institutions, healthcare personnel, international travelers, and household contacts of immunocompromised persons 4, 5
  • Persons born before 1957: Generally considered immune and do not require vaccination 3

Rationale for Two Doses

The primary justification for the two-dose schedule is that approximately 5% of children fail to develop immunity after the first dose (primary vaccine failure). 3, 1 The second dose provides a second opportunity for immunization rather than addressing waning immunity, which is not a major cause of vaccine failure. 3

After two doses, at least 95% of recipients develop long-lasting immunity. 2

Special Circumstances

High-Risk Areas for Measles

  • In counties with large inner-city populations, recent outbreaks, or more than five cases among preschool-aged children in the last 5 years, the first dose should be administered at 12 months (rather than waiting until 15 months). 3

International Travel

  • Children ≥12 months: Should receive two doses separated by at least 28 days before departure 3
  • Infants 6-11 months: Should receive one dose before departure, but this does not count toward the routine two-dose series and the child must be revaccinated with two doses starting at 12-15 months 3, 1, 2

Outbreak Settings

  • During measles outbreaks, all persons at risk should have documentation of two doses given at least 1 month apart after the first birthday 1
  • During mumps outbreaks specifically: A third dose may be recommended for persons at increased risk, but this is the only scenario where a third dose is indicated 1

HIV-Infected Persons

  • MMR vaccination is recommended for all HIV-infected persons aged ≥12 months who do not have evidence of severe immunosuppression 3, 5
  • The same two-dose schedule applies: first dose at 12-15 months and second dose at 4-6 years 5

Vaccine Interchangeability

Both available MMR vaccines in the United States (M-M-R II and PRIORIX) are fully interchangeable for all indications. 1, 2 Either vaccine can be used for any dose in the series without needing to restart or add extra doses.

Common Pitfalls to Avoid

  • Do not restart the series if delayed: If a child is behind schedule, simply administer the missed doses at least 28 days apart—there is no need to restart regardless of time elapsed 2
  • Do not count doses given before 12 months: Infants vaccinated before their first birthday (except in specific outbreak or travel situations) should be considered potentially susceptible and require the full two-dose series starting at 12 months 3
  • Do not confuse mumps outbreak recommendations with routine care: A third dose is only indicated during mumps outbreaks for high-risk individuals, not for routine measles or rubella protection 1

References

Guideline

Measles Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

MMR Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rubella Vaccine Administration and Schedule

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.